MedPath
NMPA Approval

Poliomyelitis Vaccine (Vero Cell),Inactivated, Sabin Strains

国药准字S20237012

November 6, 2023

国药准字S20170006

Drug Information

Sabin株脊髓灰质炎灭活疫苗(Vero细胞)

注射剂

2.5mL/瓶(5次人用剂量,仅供出口)。每1次人用剂量0.5mL,每剂含脊髓灰质炎病毒抗原量为Ⅰ型15DU,Ⅱ型45DU,Ⅲ型45DU。

生物制品

November 6, 2023

Company Information

Applicant Company

北京市北京经济技术开发区博兴二路9号院4号楼2层205室

Manufacturing Company

北京市北京经济技术开发区博兴二路6、9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sabin株脊髓灰质炎灭活疫苗(Vero细胞) - NMPA 批准文号 | MedPath